These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8984333)

  • 41. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for testing thrombolysis in acute ischaemic stroke. MAST Group.
    Hommel M; Cornu C
    Clin Trials Metaanal; 1993 Nov; 28(6):345-56. PubMed ID: 10172266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?
    D'Addesio JP
    N Engl J Med; 1998 Mar; 338(11):762; author reply 762-3. PubMed ID: 9499172
    [No Abstract]   [Full Text] [Related]  

  • 46. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?
    Kirshner HS
    N Engl J Med; 1998 Mar; 338(11):761-2; author reply 762-3. PubMed ID: 9499171
    [No Abstract]   [Full Text] [Related]  

  • 48. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombolysis for acute stroke.
    von Kummer R; Bozzao L
    JAMA; 1996 Apr; 275(13):984-5. PubMed ID: 8596250
    [No Abstract]   [Full Text] [Related]  

  • 50. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke.
    Pancioli A; Brott T; Donaldson V; Miller R
    Ann Emerg Med; 1997 Aug; 30(2):227-9. PubMed ID: 9250652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH
    Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombolytic therapy for acute ischaemic stroke.
    Muir K; Lees KR
    Lancet; 1997 Nov; 350(9089):1476-7; author reply 1477. PubMed ID: 9371189
    [No Abstract]   [Full Text] [Related]  

  • 53. Tissue plasminogen activator for acute ischemic stroke.
    Friedman HS
    N Engl J Med; 1996 May; 334(21):1405; author reply 1406. PubMed ID: 8614437
    [No Abstract]   [Full Text] [Related]  

  • 54. More on thrombolytic therapy for acute stroke.
    Sluss MP
    JAMA; 1998 Apr 22-29; 279(16):1262. PubMed ID: 9565002
    [No Abstract]   [Full Text] [Related]  

  • 55. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage.
    Berridge DC; Makin GS; Hopkinson BR
    Br J Surg; 1989 Dec; 76(12):1230-3. PubMed ID: 2514002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombolysis for stroke.
    Easton JD
    Cerebrovasc Dis; 1998; 8(4):191-7. PubMed ID: 9684057
    [No Abstract]   [Full Text] [Related]  

  • 57. Mental Dullness after thrombolytic therapy.
    Woo KS; Chan HC; Poon WS
    Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
    [No Abstract]   [Full Text] [Related]  

  • 58. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy.
    Simoons ML; Maggioni AP; Knatterud G; Leimberger JD; de Jaegere P; van Domburg R; Boersma E; Franzosi MG; Califf R; Schröder R
    Lancet; 1993 Dec 18-25; 342(8886-8887):1523-8. PubMed ID: 7902905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue plasminogen activator for acute ischemic stroke.
    Qureshi N
    N Engl J Med; 1996 May; 334(21):1406. PubMed ID: 8614439
    [No Abstract]   [Full Text] [Related]  

  • 60. Intracerebellar fatal haemorrhage after thrombolytic therapy of suspected non-Q-wave myocardial infarction.
    Partanen HJ; Nieminen MS
    Lancet; 1990 Oct; 336(8719):883. PubMed ID: 1976910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.